Personal information

Activities

Collapse all

Employment (1)

University of Michigan: Ann Arbor, MI, US

(Pediatric Hematology-Oncology)
Employment
Source: Self-asserted source
Carl Koschmann

Works (10)

Liquid biopsy in H3K27M diffuse midline glioma

Neuro-Oncology
2024-05-03 | Journal article
DOI: 10.1093/neuonc/noad229
Contributors: Jina Patel; Rayan Aittaleb; Robert Doherty; Ananya Gera; Benison Lau; Dana Messinger; Jack Wadden; Andrea Franson; Amanda Saratsis; Carl Koschmann
Source: check_circle
Crossref

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma

Neuro-Oncology
2024-05-03 | Journal article
DOI: 10.1093/neuonc/noae001
Contributors: Yazmin Odia; Carl Koschmann; Nicholas A Vitanza; Peter de Blank; Dolly Aguilera; Jeffrey Allen; Doured Daghistani; Matthew Hall; Ziad Khatib; Cassie Kline et al.
Source: check_circle
Crossref

Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201

Neuro-Oncology
2024-04-05 | Journal article
DOI: 10.1093/neuonc/noad222
Contributors: Dazhuan Eric Xin; Yunfei Liao; Rohit Rao; Sean Ogurek; Soma Sengupta; Mei Xin; Arman Esshaghi Bayat; William L Seibel; Richard T Graham; Carl Koschmann et al.
Source: check_circle
Crossref

Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology

JCO Precision Oncology
2024-03 | Journal article
DOI: 10.1200/PO.23.00539
Contributors: Michelle F. Jacobs; Joshua W. Goldman; Sarah Austin; Erika S. Koeppe; Andrea M. Murad; Carl J. Koschmann; Arul M. Chinnaiyan; Rajen J. Mody
Source: check_circle
Crossref

Enhancing GD2 CAR T-cell therapy with IGF-1R blockade: Are DIPG CAR T cells ready for combinatorial therapy?

Neuro-Oncology
2022-07-01 | Journal article
DOI: 10.1093/neuonc/noac073
Contributors: Andrea Franson; Carl Koschmann
Source: check_circle
Crossref

Ultra-Rapid Somatic Variant Detection via Real-Time Threshold Sequencing

2021-05-17 | Other
DOI: 10.1101/2021.05.14.444172
Contributors: Jack Wadden; Brandon Newell; Joshua Bugbee; Robert P. Dickson; Carl Koschmann; David Blaauw; Satish Narayanasamy; Reetuparna Das
Source: check_circle
Crossref

Molecular insights into malignant progression of atypical choroid plexus papilloma

Molecular Case Studies
2021-02 | Journal article
DOI: 10.1101/mcs.a005272
Contributors: Maxim Yankelevich; Jonathan L. Finlay; Hamza Gorsi; William Kupsky; Daniel R. Boue; Carl J. Koschmann; Chandan Kumar-Sinha; Rajen Mody
Source: check_circle
Crossref

Prolonged survival in a patient with a cervical spine H3K27M-mutant diffuse midline glioma

BMJ Case Reports
2019-10 | Journal article
DOI: 10.1136/bcr-2019-231424
Contributors: Kelsey Peters; Drew Pratt; Carl Koschmann; Denise Leung
Source: check_circle
Crossref

Successful treatment of aTSC2-mutant glioblastoma with everolimus

BMJ Case Reports
2019-05-31 | Journal article
DOI: 10.1136/bcr-2018-227734
Contributors: Andrew H Zureick; Kathryn A McFadden; Rajen Mody; Carl Koschmann
Source: check_circle
Crossref

Integrating RNA sequencing into neuro-oncology practice

Translational Research
2017-11 | Journal article
DOI: 10.1016/j.trsl.2017.06.013
Contributors: David S. Rogawski; Nicholas A. Vitanza; Angela C. Gauthier; Vijay Ramaswamy; Carl Koschmann
Source: check_circle
Crossref
How many people are using ORCID?